Stem Cell Therapeutic and Research Reauthorization Act of 2025
What does the HR 5160 do?
HR 5160 is a House bill sponsored by Rep. Christopher H. Smith (R-NJ-4). The C.W. Bill Young Cell Transplantation Program is a federally administered system, run by the Health Resources and Services Administration, that identifies, matches, and distributes bone marrow and cord blood units for transplantation for patients without a matched biologically related donor; the National Cord Blood Inventory (Section 2 of the Stem Cell Therapeutic and Research Act of 2005) contracts with qualified cord blood banks to build and maintain an inventory goal of at least 150,000 units of high-quality cord blood. This bill adds $33.009M of appropriations authorization for each of fiscal years 2027 through 2031 for the C.W. Bill Young Cell Transplantation Program on top of the existing $31.009M for FY2022 through FY2026, and extends the National Cord Blood Inventory authorization by striking "2026" and inserting "2031".
Did HR 5160 pass? Where it stands
As of July 24, 2026, HR 5160 has passed the House.
Status: Passed House
Latest vote: House Passed by voice vote on July 20, 2026
Outlook: Likely
Key provisions
- What the Program Does
- Identifies, matches, and distributes bone marrow and cord blood units for transplantation
- Runs a national single point of access for transplant physicians and patients
- Runs a patient advocacy and case management office
- Recruits bone marrow and cord blood donors, with priority to underrepresented populations
- Contracts with qualified cord blood banks to build the National Cord Blood Inventory (goal: at least 150,000 high-quality units)
- Program Authorization Increased
- Existing $31.009M-per-year authorization for FY2022 through FY2026 preserved
- Adds $33.009M for each of fiscal years 2027 through 2031
- Effectively a $2M-per-year increase over the FY2022-2026 authorization
- Cord Blood Inventory Extended
- Amends Section 2(g) of the Stem Cell Therapeutic and Research Act of 2005
- Strikes "2026" and inserts "2031"
- Extends existing $23M-per-year National Cord Blood Inventory authorization through FY2031
Last updated July 23, 2026